Alnylam pharmaceuticals files patent infringement suits against pfizer and moderna

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny) the leading rnai therapeutics company, announced today that it has separately filed suit in united states district court for the district of delaware against pfizer, inc. and moderna, inc., seeking damages for infringement of u.s. patent no. 11,246,933 (the “'933 patent”) in the parties' manufacture and sale of their messenger rna (mrna) covid-19 vaccines. the patent relates to alnylam's biodegradable cationic lipid
ALNY Ratings Summary
ALNY Quant Ranking